Previous Article | Next Article 
Journal of Clinical Microbiology, August 1999, p. 2493-2497, Vol. 37, No. 8
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Phialemonium Fungemia: Two
Documented Nosocomial Cases
Josep
Guarro,1,*
Marcio
Nucci,2
Tiyomi
Akiti,2
Josepa
Gené,1
Josep
Cano,1
M. Da Gloria C.
Barreiro,2 and
Carme
Aguilar1
Unitat de Microbiologia, Facultat de Medicina
i Ciències de la Salut, Universitat Rovira i Virgili, 43201-Reus,
Spain,1 and Laboratorio de Micologia,
Hospital Universitario Clementino Fraga Filho, Universidade Federal
do Rio de Janeiro, Rio de Janeiro, Brazil2
Received 21 December 1998/Returned for modification 18 February
1999/Accepted 30 April 1999
 |
ABSTRACT |
Two fungal isolates recovered from the blood of two
immunosuppressed patients are described as Phialemonium
curvatum. One patient died, while the other, who was infected
with Exophiala jeanselmei at the same time, survived after
successful treatment with itraconazole. Analysis of internal
transcribed spacer sequences demonstrated that the isolates belonged to
the same strain and that the source of infection was probably a
catheter. The taxonomic position of P. curvatum is
discussed, and Phialemonium dimorphosporum is considered a
synonym. The in vitro inhibitory activities of six antifungal agents
(amphotericin B, itraconazole, ketaconazole, miconazole, flucytosine,
and fluconazole) were determined against seven isolates of
Phialemonium. Except for flucytosine, all of them were
remarkably effective. Phialemonium should be added to the
list of potential causes of nosocomial fungemia in cancer patients.
 |
INTRODUCTION |
The number of infections caused by
hyaline filamentous fungi in immunocompromised patients is continuously
increasing. Many fungal genera are responsible for severe infections in
these patients and cause a high degree of mortality. Among them there
is a group of morphologically related fungi such as
Fusarium, Acremonium, Cylindrocarpon,
Lecythophora, and Phialemonium. The
identification of the form-species level or form-genus level is usually
difficult, especially when cultures of clinical isolates are not fully
sporulated or are degenerated. Fusarium and
Acremonium species are the most common and are the most
resistant to antifungal therapy (4, 5).
Phialemonium spp. have been isolated from localized
infections, such as peritonitis (7) and endocarditis
(15), from an infection in a burned child (9),
and from other clinical sources (2). Sometimes the causal
relationship of these species with the diseases was not proven. Reports
concerning infections in animals also exist (8). We present
two cases of Phialemonium curvatum infection from the same hospital.
 |
CASE REPORTS |
Patient 1.
A 41-year-old Brazilian man suffering a relapse of
acute lymphocytic leukemia was admitted to the Hematology Unit of the
Hospital Universitario Clementino Fraga Filho on 21 January 1997, where he was successfully treated with broad-spectrum antibiotics for febrile
neutropenia. The final diagnosis was unexplained fever. On 14 February,
5 days after a course of chemotherapy, he was readmitted and suffered
from malaise, epigastric pain, and fever. He was severely neutropenic.
Blood samples for culture were drawn from a peripheral vein and from a
totally implanted catheter that had been in place for 7 months. He was
started on treatment with ceftazidine, amikacin, and teicoplanin. On
day 4 the catheter was removed, a new blood sample for culture was
taken from a peripheral vein, and treatment with amphotericin B (1 mg/kg of body weight daily) was started because of the growth of a mold
in the culture of blood taken from the catheter. The blood sample for
culture taken on day 4 also tested positive for a morphologically
identical fungus. The patient remained febrile and neutropenic and
complained of myalgia. Twelve days after the catheter was removed,
there were erythema and a secretion in the area of insertion of the previous port. A biopsy of this tissue was performed. Ten days later
sinusitis developed. The patient remained febrile, and the dose of
amphotericin B was increased to 1.5 mg/kg. The patient subsequently
developed abdominal distention, generalized edema, psychosis, and
orbital cellulitis. On 12 March a new blood sample for culture taken
from a peripheral vein grew a filamentous fungus similar to the
previous ones. The patient developed respiratory distress, and
orotracheal intubation was performed. He later developed acute renal
failure and hypotension and died on 4 April. A Phialemonium sp. grew from all the blood cultures as well as from the biopsied tissue. Histopathologic examination did not show hyphae.
Patient 2.
A 37-year-old man was admitted to the Hematology
Unit of the Hospital Universitario Clementino Fraga Filho in January
1997 for an autologous stem cell transplant for the treatment of
relapsed Hodgkin's disease. The patient had a history of high fever 1 month earlier when a Hickman catheter was being manipulated for stem cell collection. A culture of a blood sample taken from the catheter and a culture of a specimen from the stem cell bag grew Exophiala jeanselmei. At the time of admission the patient was afebrile, and
physical examination was unremarkable. The patient was given itraconazole (200 mg daily), the catheter was replaced, and high-dose chemotherapy was started. Two days after stem cell infusion the patient
became neutropenic and developed a fever. New blood samples for culture
were drawn, and treatment with ceftazidime and teicoplanin was started.
E. jeanselmei grew in the blood culture, and the dosage of
itraconazole was increased to 400 mg daily. Since the patient remained
febrile, another blood sample for culture was taken from a peripheral
vein and the catheter was removed. Two days later, neutrophil counts
rose to 3,000 per mm3, and because the patient was
afebrile, he was discharged and itraconazole was discontinued. Later, a
Phialemonium sp. grew from the blood culture. No new fever
or signs of infection appeared in the 6 months following the patient's discharge.
 |
MATERIALS AND METHODS |
Isolate identification.
The fungal isolates from patients 1 and 2 were referred to the Microbiology Unit of the Rovira i Virgili
University in Reus, Spain, for identification and susceptibility studies.
Morphological study.
The two isolates (FMR 6321 from patient
1 and FMR 6322 from patient 2) were subcultured on potato dextrose agar
and oatmeal agar and were incubated in darkness at 25°C for
identification purposes. They were compared with the following strains:
Phialemonium obovatum CBS 279.76 and CBS 730.97, P. curvatum CBS 490.82, and Phialemonium dimorphosporum
CBS 491.82 and FMR 3940.
Molecular studies.
All strains mentioned above were
processed for PCR amplification and restriction fragment length
polymorphism (RFLP) analysis. The fungal DNA was isolated as described
by Estruch et al. (1), with some modifications. The strains
were grown in Sabouraud broth on an orbital shaker at 250 rpm and
25°C. Mycelium was recovered by filtration through nytal mesh (pore
size, 42 µm), washed with distilled water, blotted with paper towels,
frozen in liquid nitrogen, and ground to a fine powder with a mortar
and pestle. The powder was incubated for 1 h at 65°C in 1 to 2 ml of extraction buffer (Tris HCl, 200 mM; NaCl, 250 mM; EDTA, 25 mM;
sodium dodecyl sulfate, 0.5% [pH 8]). The lysate was extracted with
phenol-chloroform-isoamyl alcohol (25:24:1), and DNA was recovered by
isopropanol precipitation. The pellet was washed with 70% (vol/vol)
ethanol, dried under vacuum, and resuspended in TE (Tris HCl, 10 mM;
EDTA, 1 mM [pH 8]). The internal transcribed spacer (ITS) ribosomal
DNA (rDNA) was amplified as described by Henrion et al. (6),
with some modifications (3). Primers ITS5 and ITS4 were used
to amplify the region corresponding to the ITS, including the 5.8S
rDNA, plus a small portion (the primer region) of the 18S and the 28S rDNA genes of the different strains (16). The PCR was
performed in a Perkin-Elmer 2400 thermal cycler with the faster ramp
times, as follows: 40 cycles of 30 s at 95°C, 60 s at
50°C, and 60 s at 72°C, followed by a final extension of 7 min
at 72°C. The molecular sizes of amplified DNA were estimated by
comparison with those in a lane with a standard 100-bp DNA ladder
(Gibco BRL, Life Technologies, Barcelona, Spain). Restriction
endonucleases CfoI (GCG/C) and HinfI
(G/ANTC) were used in separate digestion reactions with PCR-amplified
products by following the manufacturer's recommendations (Boehringer
Mannheim, Mannheim, Germany). RFLP analysis was performed by loading
the digestion reaction mixture onto 2% Agarose MP (Boehringer Mannheim), and the digestion products were stained for 30 min in
ethidium bromide as described by Sambrook et al. (14).
The ITS regions of the two isolates from the patients and the type
strain of P. dimorphosporum (CBS 491.82) were sequenced. The
protocol with the Taq DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Gouda, The Netherlands) was used for sequencing. The reactions were performed with primers ITS5 and ITS4
(16) and were run on a 310 DNA sequencer (Applied
Biosystems). The sequences were aligned with the Autoassembler computer
program (Applied Biosystems).
Antifungal susceptibility testing.
The two isolates from the
patients and two additional isolates of P. dimorphosporum,
two isolates of P. obovatum, and one isolate of P. curvatum, all from various sources, were tested to determine their
susceptibilities to six antifungal drugs (amphotericin B, flucytosine,
fluconazole, itraconazole, ketoconazole, and miconazole). Tests were
performed by a previously described microdilution method (12) roughly according to the National Committee for
Clinical Laboratory Standards' guidelines (10) by using
RPMI 1640 medium buffered to pH 7 with 0.165 M
morpholinepropanesulfonic acid, an inoculum of 1.6 × 104 to 2.2 × 104 CFU/ml, an incubation
temperature of 30°C, a second-day reading (48 h), and an additive
drug dilution procedure.
Nucleotide sequence accession numbers.
The ITS sequences
were deposited in the European Molecular Biology Laboratory (EMBL)
under the following accession numbers: AJ 012298 for strain CBS 491.82, AJ 012299 for strain FMR 6321, and AJ 012300 for strain FMR 6322.
 |
RESULTS |
Morphological study.
The colonies of both isolates on
potato dextrose agar were white and cottony, reaching 36 to 38 mm in
diameter after 7 days. They then became cream colored, and small areas
of the colonies became light brown, and these light brown areas were
also visible on the reverse. No diffusible pigment was produced.
Colonies on oatmeal agar were flat and white with sparse aerial mycelia
and reached a diameter of 39 to 40 mm. Microscopically, vegetative hyphae were hyaline to pale brown and ranged from 2 to 4 µm in width,
conidiogenous cells (phialides and adelophialides) ranged from 2 to 30 µm in length (Fig. 1A), and conidia
were hyaline, cylindrical to allantoid (3 to 6 by 0.8 to 2 µm), or
ellipsoidal to obovate (2.8 to 4.5 by 1.5 to 2.5 µm) (Fig. 1B). These
characteristics were compared with those of the three described species
of Phialemonium, and the clinical isolates were
morphologically identified as P. dimorphosporum, although
the RFLP patterns of this species are identical to those of P. curvatum.

View larger version (106K):
[in this window]
[in a new window]
|
FIG. 1.
P. curvatum FMR 6321. (A) Conidiogenous cells
and conidia. (B) Conidial morphology. Magnification, with Nomarski
optics, ×1,600.
|
|
Molecular study.
All the PCR products had an approximate
molecular size of 600 bp. The restriction digests are shown in Fig.
2A and B. Digestion with
CfoI (Fig. 2A) showed two very different band patterns. One of them was shared by the isolates of P. dimorphosporum
(isolates CBS 491.82 and FMR 3940), the two strains from the
patients (strains FMR 6322 and FMR 6321), and the strain of P. curvatum (strain CBS 490.82) and consisted of two bands of
approximately 325 and 260 bp. The other pattern, corresponding to the
strains of P. obovatum (strains CBS 730.97 and CBS 279.76),
consisted of two bands of approximately 325 bp (identical to that of
the other species) and another one of 180 bp. The pattern groups were
similar by HinfI digestion (Fig. 2B), which yielded a
wide band of 300 bp (probably a doublet) shared by the patient isolates
and the strains of P. dimorphosporum and P. curvatum, while the P. obovatum isolates showed two
bands of 150 and 125 bp. From the alignments of the sequences
(Fig. 3), we can see only 1 nucleotide
difference (position 549) between the two patient isolates (isolates
FMR 6321 and FMR 6322) and 10 nucleotide differences between those isolates and the type strain of P. dimorphosporum
(strain CBS 491.82).

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 2.
(A) PCR products cleaved by CfoI and
separated on a 2% agarose gel. Lane m, 100-bp DNA ladder (Gibco BRL)
used as a size marker; lanes 1 and 4, P. dimorphosporum CBS
491.82 and FMR 3940, respectively; lanes 2 and 3, patient isolates FMR
6322 and FMR 6321, respectively; lane 5, P. curvatum CBS
490.82; lanes 6 and 7, P. obovatum CBS 730.97 and CBS
279.76, respectively. (B) PCR products cleaved by HinfI
and separated on a 2% agarose gel. Lane m, 100-bp DNA ladder (Gibco
BRL) used as a size marker; lanes 1 to 7 are as described above for
panel A.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 3.
Alignment of ITS1, 5.8S gene, and ITS2 of P. dimorphosporum CBS 491.82 and patient isolates FMR 6321 and FMR
6322. CBS 491.82 is used as the leading strand. Dots indicate
nucleotides identical to the reference sequence (the CBS 491.82 sequence).
|
|
In vitro antifungal susceptibility.
The data from the
antifungal susceptibility testing of all Phialemonium
isolates generally demonstrated low MICs except for those of
flucytosine. Examination of the minimal fungicidal concentrations (MFCs) revealed that the majority of isolates displayed a higher degree
of resistance. The MICs and MFCs for P. obovatum, with some
exceptions, were higher than those for the three species tested (Table
1).
 |
DISCUSSION |
The anamorphic genus Phialemonium was proposed in 1983 to accommodate some filamentous fungi with morphological features that fell between those of Acremonium and Phialophora
(2). Three species, P. obovatum, P. curvatum, and P. dimorphosporum, were distinguished in
the genus, mainly on the basis of the shape of their conidia, which are
obovate in P. obovatum, allantoid in P. curvatum,
and both allantoid and obovate or ellipsoidal in P. dimorphosporum. An additional characteristic used to separate the
species was the color of the colony, which is greenish in P. obovatum and white but becoming grayish in P. curvatum.
The colonies of P. dimorphosporum are similar to those of
P. curvatum, although they may become pale vinaceous buff.
However, further reports describing clinical isolates of this genus
demonstrated that the distinction of the species was not so easy in
practice. Important phenotypic variations, which mainly depend on the
culture conditions, are shown by the isolates of this genus
(7). This confusion was reported in recent articles, in
which King et al. (7) pointed out that one clinical isolate
morphologically resembled both P. dimorphosporum and
P. curvatum, and Schonheyder et al. (15) also
found difficulties in characterizing another clinical isolate
tentatively identified as P. curvatum. Our study
corroborates these findings and demonstrates that only two species in
the genus Phialemonium can be considered distinct. The two
patient isolates were initially identified morphologically as P. dimorphosporum, but RFLP analysis of PCR products obtained with
the enzymes HinfI and CfoI confirmed that
P. dimorphosporum and P. curvatum are the same
species and that this species can easily be differentiated with
molecular markers from P. obovatum. Because P. curvatum has priority over P. dimorphosporum, the
second species should be considered a synonym of the first one.
Only a few previously documented cases of Phialemonium
infections exist. In 1975, P. obovatum was involved in an
infection in a burned child. The fungus was recovered from biopsy
specimens of cutaneous and subcutaneous tissue obtained antemortem from thermal burn wounds and postmortem from spleen tissue and three burn
sites. No antifungal treatment for this patient was mentioned (9). More recently, a few new cases have been described. Two of them were in renal transplant recipients, one of whom suffered peritonitis and the other of whom had a phaeohyphomycotic cyst on his
foot. The species involved were P. obovatum and probably P. curvatum, respectively (7). Another strain
probably belonging to the species P. curvatum was found to
be associated with Streptococcus sanguis in a patient with
endocarditis involving a porcine aortic valve prosthesis. It was
suggested that the Phialemonium infection evolved
insidiously during open heart surgery by contaminating the prosthesis.
This then led to a hematogenous streptococcal infection which caused
the death of the patient (15).
To our knowledge, the cases of fungemia described here are the first
cases of fungemia caused by Phialemonium ever reported. It
is worth mentioning that both patients were in the same ward of the
bone marrow transplant unit at the same time (patient 1 was admitted in
January 1997 for a short period, while patient 2 was already in the
hospital). This suggests that they acquired the infection from the same
source, which was probably the catheters, since the isolates from the
two patients grew from blood taken from central venous catheters.
Moreover, molecular data showed that both isolates were actually
identical. So, their genetic identities and the fact that both patients
were in the same hospital unit confirm our hypothesis of a nosocomial
acquisition of the infections.
For only two of the previously reported isolates from patients with
Phialemonium infection, which were described in the same article (7), were in vitro susceptibility data provided. The tests were performed in two different laboratories, and the MICs of
amphotericin B, itraconazole, and ketoconazole were completely different for both isolates. One of them was susceptible to
amphotericin B and resistant to itraconazole and ketoconazole and the
susceptibility of the other one was the exact opposite of that of the
first one. Phialemonium spp. are morphologically similar to
other well-known opportunistic pathogens such as Fusarium
spp. and Acremonium spp. However, the susceptibilities of
the isolates of these two genera, at least in vitro, are very
different, and members of both genera display universal antifungal
resistance (4, 13). Due to the lack of practical data
concerning the antifungal treatment of infections caused by
Phialemonium spp., it is impossible to predict the most
adequate treatment. Only one of the previous reports of
Phialemonium infections mentioned the treatment that was
applied. This was for a patient with peritonitis whose dialysate
catheter was removed and who was then treated with amphotericin B,
ketoconazole, flucytosine, and, finally, fluconazole until repeated
cultures of peritoneal fluid yielded no growth (7). On the
basis of the good in vitro results of our study, it seems that several alternative treatments could be used, although further study is required.
The outcomes for our patients were quite different. The first patient,
who developed multiple organ failure and who had had positive blood
cultures on three previous occasions, died, despite removal of the
catheter and the administration of high doses of amphotericin B, which
had been demonstrated to have efficacy in vitro. The second patient
improved with catheter removal and oral treatment with itraconazole,
which had also been demonstrated to have efficacy in vitro. However,
the most important difference was that in the second patient the abone
marrow recovered, but the first patient died with profound and
prolonged neutropenia. We realize that the infection in the second
patient was not fully substantiated on the basis of only a single
positive culture for P. curvatum. Fungi present on the skin
or other surfaces can be picked up through transdermal hypodermic or
catheter ports and can contaminate blood cultures, and we demonstrated
that this fungus was present in the hospital environment.
Unfortunately, it was not possible to perform a second blood culture
because 2 days later the patient was afebrile and was discharged. Bone marrow recovery for determination of the prognosis for cancer patients
with fungemia has been shown to be very important (11).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unitat de
Microbiologia, Departament de Ciències Mèdiques
Bàsiques, Facultat de Medicina i Ciències de la Salut,
Universitat Rovira i Virgili, Carrer Sant Llorenç 21, 43201-Reus,
Tarragona, Spain. Phone: 34 977759359. Fax: 34 977759322. E-mail:
umb{at}fmcs.urv.es.
 |
REFERENCES |
| 1.
|
Estruch, J. J.,
C. Antuña,
S. Ferrer, and D. Ramón.
1989.
Aislamiento de DNA genómico de Trichophyton mentagrophytes.
Rev. Iber. Micol.
5:62-66.
|
| 2.
|
Gams, W., and M. R. McGinnis.
1983.
Phialemonium, a new anamorph genus intermediate between Phialophora and Acremonium.
Mycologia
75:977-987.
|
| 3.
|
Gené, J.,
J. M. Guillamón,
J. Guarro,
I. Pujol, and K. Ulfig.
1996.
Hormographiella aspergillata anamorph of Coprinus cinereus, a human opportunistic fungus: molecular characterization and antifungal susceptibility.
Antonie Leeuwenhoek
70:49-57.
|
| 4.
|
Guarro, J.,
W. Gams,
I. Pujol, and J. Gené.
1997.
Acremonium species: new emerging fungal opportunists. In vitro antifungal susceptibilities and review.
Clin. Infect. Dis.
25:1222-1229[Medline].
|
| 5.
|
Guarro, J., and J. Gené.
1995.
Opportunistic fusarial infections in humans.
Eur. J. Clin. Microbiol. Infect. Dis.
14:741-754[Medline].
|
| 6.
|
Henrion, B.,
G. Chevalier, and F. Martin.
1994.
Typing truffle species by PCR amplification of the ribosomal DNA spacers.
Mycol. Res.
98:37-43.
|
| 7.
|
King, D.,
L. Pasarell,
D. M. Dixon,
M. R. McGinnis, and W. G. Merz.
1993.
A phaeohyphomycotic cyst and peritonitis caused by Phialemonium species and a reevaluation of its taxonomy.
J. Clin. Microbiol.
31:1804-1810[Abstract/Free Full Text].
|
| 8.
|
Lomax, L. G.,
J. R. Cole,
A. A. Padhye,
L. Ajello,
F. W. Chanler, and B. R. Smith.
1986.
Osteolytic phaeohyphomycosis in a German shepherd dog caused by Phialemonium obovatum.
J. Clin. Microbiol.
23:987-991[Abstract/Free Full Text].
|
| 9.
|
McGinnis, M. R.,
W. Gams, and M. N. Goodwin, Jr.
1986.
Phialemonium obovatum infection in a burned child.
J. Med. Vet. Mycol.
24:51-55[Medline].
|
| 10.
|
National Committee for Clinical Laboratory Standards.
1997.
Reference method for broth dilution antifungal susceptibility testing of yeast. Standard M27-A.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 11.
|
Nucci, M.,
M. I. Silveira,
N. Spector,
F. Silveira,
E. Velasco,
T. Akiti,
G. Barreiros,
A. Derossi,
A. L. Colombo, and W. Pulcheri.
1998.
Risk factors for death in cancer patients with fungemia.
Clin. Infect. Dis.
27:107-111[Medline].
|
| 12.
|
Pujol, I.,
J. Guarro,
C. Llop,
L. Soler, and J. Fernández-Ballart.
1996.
Comparison of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi.
Antimicrob. Agents Chemother.
40:2103-2110.
|
| 13.
|
Pujol, I.,
J. Guarro,
J. Gené, and J. Sala.
1997.
In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains.
J. Antimicrob. Chemother.
39:163-167[Abstract/Free Full Text].
|
| 14.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 15.
|
Schonheyder, H. C.,
H. E. Jensen,
W. Gams,
O. Nyvad,
P. Van Nga,
B. Aalbaek, and J. Stenderup.
1996.
Late bioprosthetic valve endocarditis caused by Phialemonium aff. curvatum.
J. Med. Vet. Mycol.
34:209-214[Medline].
|
| 16.
|
White, T. J.,
T. Bruns,
S. Lee, and J. Taylor.
1990.
Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, p. 315-322.
In
M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols. A guide to methods and applications. Academic Press, Inc., San Diego, Calif.
|
Journal of Clinical Microbiology, August 1999, p. 2493-2497, Vol. 37, No. 8
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Jung, J. H., Lee, J. E., Lee, C. H., Kim, S. S., Lee, B. U.
(2009). Treatment of Fungal Bioaerosols by a High-Temperature, Short-Time Process in a Continuous-Flow System. Appl. Environ. Microbiol.
75: 2742-2749
[Abstract]
[Full Text]
-
Willinger, B., Obradovic, A., Selitsch, B., Beck-Mannagetta, J., Buzina, W., Braun, H., Apfalter, P., Hirschl, A. M., Makristathis, A., Rotter, M.
(2003). Detection and Identification of Fungi from Fungus Balls of the Maxillary Sinus by Molecular Techniques. J. Clin. Microbiol.
41: 581-585
[Abstract]
[Full Text]
-
Gavin, P. J., Sutton, D. A., Katz, B. Z.
(2002). Fatal Endocarditis in a Neonate Caused by the Dematiaceous Fungus Phialemonium obovatum: Case Report and Review of the Literature. J. Clin. Microbiol.
40: 2207-2212
[Abstract]
[Full Text]